Healthcare & Life Sciences
Type6 Therapeutics
Germany
series-a
series-a
Stage
1
Investors
About
Type6 Therapeutics uses computational biology techniques to identify and develop therapies that target disease-driving kinases, focusing on kinase-targeted drug discovery through in silico methods.
Explore Type6 Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.